Delayed
Japan Exchange
01:27:14 2024-05-10 EDT
5-day change
1st Jan Change
2,248
JPY
+1.58%
+1.26%
+18.93%
Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback announced on August 29, 2016 has expired with 1,050,000 shares for ¥271.95 million.
The company expired its plan on August 30, 2016.
Tranche Update on Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback Plan announced on September 5, 2023.
23-09-05
CI
Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback announced on September 5, 2023, has closed with
23-09-05
CI
Fuso Pharmaceutical Industries,Ltd. announces an Equity Buyback for 340,000 shares, representing 3.88% for ¥735 million.
23-09-05
CI
Fuso Pharmaceutical Industries,Ltd. authorizes a Buyback Plan.
23-09-04
CI
Fuso Pharmaceutical Industries,Ltd.(TSE:4538) dropped from S&P Global BMI Index
22-09-19
CI
Fuso Pharmaceutical Industries,Ltd.(TSE:4538) added to S&P Global BMI Index
21-09-20
CI
Fuso Pharmaceutical Industries,Ltd.(TSE:4538) dropped from S&P Global BMI Index
17-09-18
CI
Tranche Update on Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback Plan announced on September 4, 2017.
17-09-04
CI
Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback announced on September 4, 2017 has expired with 154,100 shares, representing 1.72% for ¥421.62 million.
17-09-04
CI
Fuso Pharmaceutical Industries,Ltd. announces an Equity Buyback for 200,000 shares, representing 2.24% for ¥547.2 million.
17-09-04
CI
Fuso Pharmaceutical Industries,Ltd. authorizes a Buyback Plan.
17-09-03
CI
Fuso Pharmaceutical Industries,Ltd. authorizes a Buyback Plan.
16-10-23
CI
Fuso Pharmaceutical Industries,Ltd. announces an Equity Buyback for 866 shares, for ¥2.3 million.
16-10-23
CI
Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback announced on October 24, 2016 has expired.
16-10-23
CI
Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback announced on August 29, 2016 has expired with 1,050,000 shares for ¥271.95 million.
16-08-29
CI
Tranche Update on Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback Plan announced on August 29, 2016.
16-08-29
CI
Fuso Pharmaceutical Industries,Ltd. authorizes a Buyback Plan.
16-08-28
CI
Fuso Pharmaceutical Industries,Ltd. announces an Equity Buyback for 1,300,000 shares, representing 1.44% for ¥336.7 million.
16-08-28
CI
JA Mitsui Leasing, Ltd. cancelled the acquisition of Kyobashi Parking Lot of Fuso Pharmaceutical Industries,Ltd..
13-11-20
CI
JA Mitsui Leasing, Ltd. entered into an agreement to acquire Kyobashi Parking Lot of Fuso Pharmaceutical Industries,Ltd. for ¥4 billion.
12-11-20
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Fuso Pharmaceutical Industries, Ltd. is a Japan-based company principally involved in the manufacture and sale of pharmaceuticals and medical equipment for medical purposes. The Company operates in two business segments. The Pharmaceuticals segment is involved in manufacture and sale of pharmaceutical products, including injectable drugs, which mainly focus on infusion solution, dialysis fluid for artificial kidney, as well as the manufacture and sale of medical equipment and instruments. The Real Estate segment is engaged in the leasing of real estate properties.
More about the company
1st Jan change
Capi.
+18.93% 120M +32.36% 695B +26.51% 568B -4.40% 361B +19.46% 330B +3.50% 283B +16.34% 239B +6.68% 204B -9.08% 198B +8.62% 168B
Other Pharmaceuticals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1